ArticleNAR cancer2025

Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma.

Takatoshi Shimauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.